Accuray, Inc. (ARAY)
0.5068
-0.02
(-3.06%)
USD |
NASDAQ |
Mar 05, 16:00
0.5068
0.00 (0.00%)
After-Hours: 17:03
Accuray Cash from Investing (Quarterly) : -5.596M for Dec. 31, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Abbott Laboratories | -913.00M |
| Alphatec Holdings, Inc. | -15.74M |
| Boston Scientific Corp. | -512.00M |
| Apyx Medical Corp. | -0.519M |
| Plus Therapeutics, Inc. | 1.297M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -15.99M |
| Cash from Financing (Quarterly) | -0.282M |
| Free Cash Flow | -10.71M |
| Free Cash Flow Per Share (Quarterly) | -0.1784 |
| Free Cash Flow to Equity (Quarterly) | -16.70M |
| Free Cash Flow to Firm (Quarterly) | -13.54M |
| Free Cash Flow Yield | -18.71% |